The etiology of breast cancer might be explained by 2 mechanisms, namely, differentiation and proliferation of breast epithelial cells mediated by hormonal factors. We performed a systematic review and meta-analysis to update effects of risk factors for both mechanisms. MEDLINE and EMBASE were searched up to January 2011. Studies that assessed association between oral contraceptives (OC), hormonal replacement therapy (HRT), diabetes mellitus (DM), or breastfeeding and breast cancer were eligible. Relative risks with their confidence intervals (CIs) were extracted. A random-effects method was applied for pooling the effect size. The pooled odds ratios of OC, HRT, and DM were 1.10 (95% CI = 1.03-1.18), 1.23 (95% CI = 1.21-1.25), and 1.14 (95% CI = 1.09-1.19), respectively, whereas the pooled odds ratio of ever-breastfeeding was 0.72 (95% CI = 0.58-0.89). Our study suggests that OC, HRT, and DM might increase risks, whereas breastfeeding might lower risks of breast cancer.
ParkinDMBrayFFerlayJPisaniP. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2.
LesterJ. Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies. Clin J Oncol Nurs. 2007;11:619-622.
3.
LloydOLWongSYuTWongT. Mortality mapping in Hong Kong, 1979-83 and 1984-88: feasibility study and the patterns of cancers. Asia Pac J Public Health. 1995;8:66-73.
4.
DeySSolimanAS. Cancer in the global health era: opportunities for the Middle East and Asia. Asia Pac J Public Health. 2010;22(3 suppl):75S-82S.
5.
VisvanathanKChlebowskiRTHurleyP. American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol. 2009;27:3235-3258.
6.
PerssonI. Estrogens in the causation of breast, endometrial and ovarian cancers—evidences and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol. 2000;74:357-364.
7.
AdamiHOPerssonIEkbomAWolkAPontenJTrichopoulosD. The aetiology and pathogenesis of human breast cancer. Mutat Res. 1995;333:29-35.
8.
RussoJMailoDHuYFBaloghGSheriffFRussoIH. Breast differentiation and its implication in cancer prevention. Clin Cancer Res. 2005;11(2 pt 2):931s-936s.
9.
CavalieriERoganESinhaD. Carcinogenicity of aromatic hydrocarbons directly applied to rat mammary gland. J Cancer Res Clin Oncol. 1988;114:3-9.
10.
RussoJRiveraRRussoIH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat. 1992;23:211-218.
11.
YagerJDLiehrJG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol. 1996;36:203-232.
12.
WolfISadetzkiSCataneRKarasikAKaufmanB. Diabetes mellitus and breast cancer. Lancet Oncol. 2005;6:103-111.
13.
KahlenbornCModugnoFPotterDMSeversWB. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clinic Proc. 2006;81:1290-1302.
14.
GreiserCMGreiserEMDorenM. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials. Hum Reprod Update. 2005;11: 561-573.
15.
BernierMOPlu-BureauGBossardNAyzacLThalabardJC. Breastfeeding and risk of breast cancer: a meta-analysis of published studies. Hum Reprod Update. 2000;6:374-386.
16.
LarssonSCMantzorosCSWolkA. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121:856-862.
17.
KeyJHodgsonSOmarRZ. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control. 2006;17:759-770.
18.
KhuderSASimonVJJr. Is there an association between passive smoking and breast cancer?Eur J Epidemiol. 2000;16:1117-1121.
19.
SadriGMahjubH. Passive or active smoking, which is more relevant to breast cancer. Saudi Med J. 2007;28:254-258.
20.
BergstromAPisaniPTenetVWolkAAdamiHO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91:421-430.
21.
RenehanAGTysonMEggerMHellerRFZwahlenM. Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569-578.
22.
SuzukiROrsiniNSajiSKeyTJWolkA. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis. Int J Cancer. 2009;124:698-712.
23.
StroupDFBerlinJAMortonSC. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
24.
MoherDLiberatiATetzlaffJAltmanDG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-269.
25.
HigginsJPThompsonSGDeeksJJAltmanDG. Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed.). 2003;327:557-560.
26.
Oral contraceptive use and breast cancer risk in young women. UK National Case-Control Study Group. Lancet. 1989;1:973-982.
27.
Breast cancer and combined oral contraceptives: results from a multinational study. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Br J Cancer. 1990;61:110-119.
28.
BrintonLADalingJRLiffJM. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst. 1995;87:827-835.
29.
ChieWCLiCYHuangCSChangKJYenMLLinRS. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Int J Cancer. 1998;77:219-223.
30.
ClavelFAndrieuNGairardB. Oral contraceptives and breast cancer: a French case-control study. Int J Epidemiol. 1991;20:32-38.
31.
EwertzM. Oral contraceptives and breast cancer risk in Denmark. Eur J Cancer. 1992;28A:1176-1181.
32.
GomesALGuimaraesMDGomesCCChavesIGGobbiHCamargosAF. A case-control study of risk factors for breast cancer in Brazil, 1978-1987. Int J Epidemiol. 1995;24:292-299.
33.
LeMGBachelotADoyenFKramarA. A study on the association between the use of oral contraception and cancer of breast or cervix: preliminary findings of a French study [in French]. Contracept Fertil Sex (Paris). 1985;13:553-558.
34.
LeeHPGourleyLDuffySWEsteveJLeeJDayNE. Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control. 1992;3:313-322.
35.
LeeNCRosero-BixbyLOberleMWGrimaldoCWhatleyASRoviraEZ. A case-control study of breast cancer and hormonal contraception in Costa Rica. J Natl Cancer Inst. 1987;79:1247-1254.
36.
MarchbanksPAMcDonaldJAWilsonHG. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002;346:2025-2032.
37.
MarcusPMBairdDDMillikanRCMoormanPGQaqishBNewmanB. Adolescent reproductive events and subsequent breast cancer risk. Am J Public Health. 1999;89:1244-1247.
38.
McCredieMRDiteGSGilesGGHopperJL. Breast cancer in Australian women under the age of 40. Cancer Causes Control. 1998;9:189-198.
39.
McPhersonKVesseyMPNeilADollRJonesLRobertsM. Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer. 1987;56:653-660.
40.
MeirikOLundEAdamiHOBergstromRChristoffersenTBergsjoP. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet. 1986;2:650-654.
41.
MoormanPGMillikanRCNewmanB. Oral contraceptives and breast cancer among African-American women and white women. J Natl Med Assoc. 2001;93:329-334.
42.
NewcombPALongneckerMPStorerBE. Recent oral contraceptive use and risk of breast cancer (United States). Cancer Causes Control. 1996;7:525-532.
43.
OlssonHMollerTRRanstamJ. Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. J Natl Cancer Inst. 1989;81:1000-1004.
44.
PalmerJRRosenbergLRaoRS. Oral contraceptive use and breast cancer risk among African-American women. Cancer Causes Control. 1995;6:321-331.
45.
PaulCSkeggDCSpearsGF. Oral contraceptives and risk of breast cancer. Int J Cancer. 1990;46: 366-373.
46.
Primic-ZakeljMEvstifeevaTRavniharBBoyleP. Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54. Int J Cancer. 1995;62:414-420.
47.
RookusMAvan LeeuwenFE. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group. Lancet. 1994;344:844-851.
48.
RosenbergLPalmerJRClarkeEAShapiroS. A case-control study of the risk of breast cancer in relation to oral contraceptive use. Am J Epidemiol. 1992;136:1437-1444.
49.
RosenbergLPalmerJRRaoRS. Case-control study of oral contraceptive use and risk of breast cancer. Am J Epidemiol. 1996;143:25-37.
50.
ShapiroSRosenbergLHoffmanM. Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. Am J Epidemiol. 2000;151:396-403.
51.
TavaniAGallusSLa VecchiaC. Risk factors for breast cancer in women under 40 years. Eur J Cancer. 1999;35:1361-1367.
52.
TessaroSBériaJUTomasiEBarrosAJ. Oral contraceptive and breast cancer: a case-control study [in Portuguese]. Rev Saude Publica. 2001;35:32-38.
53.
TrainaACusimanoRLiquoriM. Oral contraceptive use and breast cancer risk in areas with different incidence. A case-control study among young women. Ann N Y Acad Sci. 1996;784:564-569.
54.
UrsinGWuAHHooverRN. Breast cancer and oral contraceptive use in Asian-American women. Am J Epidemiol. 1999;150:561-567.
55.
WeinsteinALMahoneyMCNascaPCLeskeMCVarmaAO. Breast cancer risk and oral contraceptive use: results from a large case-control study. Epidemiology. 1991;2:353-358.
56.
WhiteEMaloneKEWeissNSDalingJR. Breast cancer among young U.S. women in relation to oral contraceptive use. J Natl Cancer Inst. 1994;86:505-514.
57.
WingoPALeeNCOryHWBeralVPetersonHBRhodesP. Age-specific differences in the relationship between oral contraceptive use and breast cancer. Cancer. 1993;71(4 suppl):1506-1571.
58.
MarubiniEDecarliACostaA. The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer. Results of a case-control study. Cancer. 1988;61:173-180.
59.
YuanJMYuMCRossRKGaoYTHendersonBE. Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res. 1988;48:1949-1953.
60.
AlthuisMDBroganDDCoatesRJ. Breast cancers among very young premenopausal women (United States). Cancer Causes Control. 2003;14:151-160.
61.
LiCIMathesRWMaloneKE. Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2009;18:2030-2034.
62.
NyanteSJGammonMDMaloneKEDalingJRBrintonLA. The association between oral contraceptive use and lobular and ductal breast cancer in young women. Int J Cancer. 2008;122:936-941.
63.
PhillipsLSMillikanRCSchroederJCBarnholtz-SloanJSLevineBJ. Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2009;18:1507-1514.
64.
ShantakumarSTerryMBPaykinA. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Am J Epidemiol. 2007;165:1187-1198.
65.
AlthuisMDBroganDRCoatesRJ. Hormonal content and potency of oral contraceptives and breast cancer risk among young women. Br J Cancer. 2003;88:50-57.
66.
BejiNKReisN. Risk factors for breast cancer in Turkish women: a hospital-based case-control study. Eur J Cancer Care (Engl). 2007;16:178-184.
67.
CroghanITPruthiSHaysJT. The role of smoking in breast cancer development: an analysis of a Mayo Clinic cohort. Breast J. 2009;15:489-495.
68.
DolleJMDalingJRWhiteE. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev. 2009;18:1157-1166.
69.
DorjgochooTShuXOLiHL. Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer. 2009;124:2442-2449.
70.
DumeauxVAlsakerELundE. Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study. Int J Cancer. 2003;105:844-850.
71.
DumeauxVFournierALundEClavel-ChapelonF. Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. Cancer Causes Control. 2005;16:537-544.
72.
FaheemMKhurramMJafriIA. Risk factors for breast cancer in patients treated at NORI Hospital, Islamabad. J Pak Med Assoc. 2007;57:242-245.
73.
HadjisavvasALoizidouMAMiddletonN. An investigation of breast cancer risk factors in Cyprus: a case control study. BMC Cancer. 2010;10:447.
74.
JernstromHLomanNJohannssonOTBorgAOlssonH. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing. Eur J Cancer. 2005;41:2312-2320.
75.
KamarudinRShahSAHidayahN. Lifestyle factors and breast cancer: a case-control study in Kuala Lumpur, Malaysia. Asian Pac J Cancer Prev. 2006;7:51-54.
76.
LiCIMaloneKEPorterPLWeissNSTangMTCDalingJR. Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age. Int J Cancer. 2003;107:647-651.
77.
LotfiMHCharkhattiSShobairiS. Breast cancer risk factors in an urban area of Yazd city, Iran, 2006. Acta Med Iranica. 2008;46:258-264.
78.
LumachiFFrigoACBassoUTombolanVErmaniM. Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis. Menopause. 2010;17:524-528.
79.
MaHBernsteinLRossRKUrsinG. Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res. 2006;8:R39.
80.
MaHWangYSullivan-HalleyJ. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women’s contraceptive and reproductive experiences study. Cancer Res. 2010;70: 575-587.
81.
MahouriKDehghani ZahedaniMZareS. Breast cancer risk factors in south of Islamic Republic of Iran: a case-control study. East Mediterr Health J. 2007;13:1265-1273.
82.
MontazeriASadighiJFarzadiF. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study. BMC Cancer. 2008;8:278.
83.
NewcomerLMNewcombPATrentham-DietzALongneckerMPGreenbergER. Oral contraceptive use and risk of breast cancer by histologic type. Int J Cancer. 2003;106:961-964.
84.
Norsa’adahBRusliBNImranAKNaingIWinnT. Risk factors of breast cancer in women in Kelantan, Malaysia. Singapore Med J. 2005;46:698-705.
85.
ReevesKWNessRBStoneRA. Vascular endothelial growth factor and breast cancer risk. Cancer Causes Control. 2009;20:375-386.
86.
RoddamAWPirieKPikeMC. Active and passive smoking and the risk of breast cancer in women aged 36-45 years: a population based case-control study in the UK. Br J Cancer. 2007;97:434-439.
87.
RosenbergLBoggsDAWiseLAAdams-CampbellLLPalmerJR. Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev. 2010;19:2073-2079.
88.
RosenbergLZhangYCooganPFStromBLPalmerJR. A case-control study of oral contraceptive use and incident breast cancer. Am J Epidemiol. 2009;169:473-479.
89.
RosenbergLUEinarsdottirKFrimanEI. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2006;15:2482-2488.
90.
StahlbergCPedersenATLyngeE. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Int J Cancer. 2004;109:721-727.
91.
StromBLBerlinJAWeberAL. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer. Contraception. 2004;69:353-360.
92.
SweeneyCGiulianoARBaumgartnerKB. Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women. Int J Cancer. 2007;121:2517-2523.
93.
YavariPMosavizadehMSadrol-HefaziBMehrabiY. Reproductive characteristics and the risk of breast cancer—a case-control study in Iran. Asian Pac J Cancer Prev. 2005;6:370-375.
94.
RosenbergLUMagnussonCLindstromEWedrenSHallPDickmanPW. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study. Breast Cancer Res. 2006;8:R11.
95.
ClausEBStoweMCarterD. Oral contraceptives and the risk of ductal breast carcinoma in situ. Breast Cancer Res Treat. 2003;81:129-136.
96.
GillJKPressMFPatelAVBernsteinL. Oral contraceptive use and risk of breast carcinoma in situ (United States). Cancer Causes Control. 2006;17:1155-1162.
97.
NicholsHBTrentham-DietzAEganKMTitus-ErnstoffLHamptonJMNewcombPA. Oral contraceptive use and risk of breast carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2007;16:2262-2268.
98.
RosenbergLPalmerJRWiseLAAdams-CampbellLL. A prospective study of female hormone use and breast cancer among black women. Arch Intern Med. 2006;166:760-765.
99.
LumachiFBassoSMMMarzanoBBonaminiMWaclawBUChiaraGB. Previous oral contraceptive use and breast cancer risk among pre- and postmenopausal women—retrospective study in a cohort of 979 patients. Eur J Cancer Suppl. 2010;8:220.
100.
LeeSARossRKPikeMC. An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer. 2005;92:2049-2058.
101.
ShahNRBorensteinJDuboisRW. Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis. Menopause. 2005;12:668-678.
102.
MillsPKBeesonWLPhillipsRLFraserGE. Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists. Cancer. 1989;64:591-597.
103.
RischHAHoweGR. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am J Epidemiol. 1994;139:670-683.
104.
ColditzGAHankinsonSEHunterDJ. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589-1593.
105.
FolsomARMinkPJSellersTAHongCPZhengWPotterJD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health. 1995;85(8 pt 1):1128-1132.
106.
SchuurmanAGvan den BrandtPAGoldbohmRA. Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study. Cancer Causes Control. 1995;6:416-424.
107.
ColditzGARosnerB. Use of estrogen plus progestin is associated with greater increase in breast cancer risk than estrogen alone. Am J Epidemiol. 1998;147(suppl):64S.
108.
LandoJFHeckKEBrettKM. Hormone replacement therapy and breast cancer risk in a nationally representative cohort. Am J Prev Med. 1999;17:176-180.
109.
SchairerCLubinJTroisiRSturgeonSBrintonLHooverR. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000;283:485-491.
110.
ManjerJMalinaJBerglundGBondesonLGarneJPJanzonL. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy. Int J Cancer. 2001;92:919-922.
111.
ViscoliCMBrassLMKernanWNSarrelPMSuissaSHorwitzRI. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001;345:1243-1249.
112.
CherryNGilmourKHannafordP. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet. 2002;360:2001-2008.
113.
HulleySFurbergCBarrett-ConnorE. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:58-66.
114.
de LignièresBde VathaireFFournierS. Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women. Climacteric. 2002;5:332-340.
115.
WatersDDAldermanELHsiaJ. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA. 2002;288:2432-2440.
116.
RossouwJEAndersonGLPrenticeRL. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
117.
JernstromHBendahlPOLidfeldtJNerbrandCAgardhCDSamsioeG. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the Women’s Health in the Lund Area (WHILA) study (Sweden). Cancer Causes Control. 2003;14: 673-680.
118.
BeralV. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362:419-427.
119.
TjonnelandAChristensenJThomsenBL. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer. 2004;100:2328-2337.
120.
AndersonGLLimacherMAssafAR. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;291:1701-1712.
121.
KaufmanDWPalmerJRde MouzonJ. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. Am J Epidemiol. 1991;134:1375-1385.
122.
PalmerJRRosenbergLClarkeEAMillerDRShapiroS. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study. Am J Epidemiol. 1991;134:1386-1395.
123.
HarrisRENamboodiriKKWynderEL. Breast cancer risk: effects of estrogen replacement therapy and body mass. J Natl Cancer Inst. 1992;84:1575-1582.
124.
La VecchiaCNegriEFranceschiSParazziniF. Non-contraceptive oestrogens and breast cancer: an update. Int J Cancer. 1992;50:161-162.
125.
YangCPDalingJRBandPRGallagherRPWhiteEWeissNS. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes Control. 1992;3:475-479.
126.
WeinsteinALMahoneyMCNascaPCHansonRLLeskeMCVarmaAO. Oestrogen replacement therapy and breast cancer risk: a case-control study. Int J Epidemiol. 1993;22:781-789.
127.
La VecchiaCNegriEFranceschiS. Hormone replacement treatment and breast cancer risk: a cooperative Italian study. Br J Cancer. 1995;72:244-248.
128.
LipworthLKatsouyanniKStuverSSamoliEHankinsonSETrichopoulosD. Oral contraceptives, menopausal estrogens, and the risk of breast cancer: a case-control study in Greece. Int J Cancer. 1995;62:548-551.
129.
NewcombPALongneckerMPStorerBE. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol. 1995;142:788-795.
130.
StanfordJLWeissNSVoigtLFDalingJRHabelLARossingMA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995;274:137-142.
131.
PerssonIThurfjellEBergstromRHolmbergL. Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening. Int J Cancer. 1997;72:758-761.
132.
LeviFLucchiniFPascheCLa VecchiaC. Oral contraceptives, menopausal hormone replacement treatment and breast cancer risk. Eur J Cancer Prev. 1996;5:259-266.
133.
HenrichJBKornguthPJViscoliCMHorwitzRI. Postmenopausal estrogen use and invasive versus in situ breast cancer risk. J Clin Epidemiol. 1998;51:1277-1283.
134.
MagnussonCBaronJACorreiaNBergstromRAdamiHOPerssonI. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer. 1999;81:339-344.
135.
MoormanPGKuwabaraHMillikanRCNewmanB. Menopausal hormones and breast cancer in a biracial population. Am J Public Health. 2000;90:966-971.
136.
RossRKPaganini-HillAWanPCPikeMC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000;92:328-332.
137.
KirshVKreigerN. Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada. Cancer Causes Control. 2002;13:583-590.
138.
NewcombPATitus-ErnstoffLEganKM. Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:593-600.
139.
WeissLKBurkmanRTCushing-HaugenKL. Hormone replacement therapy regimens and breast cancer risk. Obstet Gynecol. 2002;100:1148-1158.
140.
WirfaltEMattissonIGullbergBJohanssonUOlssonHBerglundG. Postmenopausal breast cancer is associated with high intakes of omega6 fatty acids (Sweden). Cancer Causes Control. 2002;13: 883-893.
141.
LiCIMaloneKEPorterPL. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA. 2003;289:3254-3263.
142.
ChenCLWeissNSNewcombPBarlowWWhiteE. Hormone replacement therapy in relation to breast cancer. JAMA. 2002;287:734-741.
143.
LucasFLCauleyJAStoneRA. Bone mineral density and risk of breast cancer: differences by family history of breast cancer. Study of Osteoporotic Fractures Research Group. Am J Epidemiol. 1998;148:22-29.
144.
SouranderLRajalaTRaihaIMakinenJErkkolaRHeleniusH. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet. 1998;352:1965-1969.
145.
PorchJVLeeIMCookNRRexrodeKMBurinJE. Estrogen-progestin replacement therapy and breast cancer risk: the Women’s Health Study (United States). Cancer Causes Control. 2002;13:847-854.
146.
KawaiMMinamiYKuriyamaS. Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study. Cancer Causes Control. 2010;21:135-145.
147.
AhernTPLashTLSorensenHTPedersenL. Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Res. 2008;10:R102.
148.
Al-ShaibaniHBu-AlayyanSHabibaSSorkhouEAl-ShamaliNAl-QallafB. Risk factors of breast cancer in Kuwait: case-control study. Iran J Med Sci. 2006;31:61-64.
149.
BakkenKAlsakerEEggenAELundE. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. Int J Cancer. 2004;112:130-134.
150.
BernatskySClarkeARamsey-GoldmanR. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus. Rheumatology (Oxford). 2004;43:1178-1181.
151.
BoydNFMartinLJLiQ. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:961-966.
152.
BrintonLARichessonDLeitzmannMF. Menopausal hormone therapy and breast cancer risk in the NIH-AARP diet and health study cohort. Cancer Epidemiol Biomarkers Prev. 2008;17:3150-3160.
153.
ChangJHGertigDMChenX. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Res. 2005;7:R513-R521.
154.
ChlebowskiRTAndersonGLGassM. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 20;304:1684-1692.
155.
CsizmadiIFriedenreichCMBryantHECourneyaKS. An analysis of the effect of selection bias on the association of hormone replacement therapy and breast cancer risk. Chronic Dis Can. 2005;26:73-79.
156.
DiergaardeBPotterJDJupeER. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:1751-1759.
157.
DingerJCHeinemannLAMöhnerSThai doMAssmannA. Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women’s Health. 2006;6:13.
158.
EgebergROlsenALoftS. Intake of whole grain products and risk of breast cancer by hormone receptor status and histology among postmenopausal women. Int J Cancer. 2009;124:745-750.
159.
EspieMDauresJPChevallierTMaresPMichelettiMCDe ReilhacP. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase. Gynecol Endocrinol. 2007;23:391-397.
160.
EwertzMMellemkjaerLPoulsenAH. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer. 2005;92:1293-1297.
161.
Flesch-JanysDSlangerTMutschelknaussE. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer. 2008;123:933-941.
162.
FournierABerrinoFRiboliEAvenelVClavel-ChapelonF. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer. 2005;114:448-454.
163.
Garcia-ClosasMBrintonLALissowskaJ. Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer. 2006;95:123-129.
164.
GarwoodERKumarASShimV. Menopausal hormone therapy and breast cancer phenotype: does dose matter?Ann Surg Oncol. 2008;15:2526-2532.
165.
GertigDMFletcherASEnglishDRMacinnisRJHopperJLGilesGG. Hormone therapy and breast cancer: what factors modify the association?Menopause. 2006;13:178-184.
166.
HadjiPGottschalkMZillerVKalderMJackischCWagnerU. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg Breast Cancer and Osteoporosis Trial (MABOT). Maturitas. 2007;56:312-321.
167.
HofvindSMollerBThoresenSUrsinG. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens. Int J Cancer. 2006;118:3112-3117.
168.
KerlikowskeKCookAJBuistDS. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010;28:3830-3837.
169.
LaceyJVJrKreimerARBuysSS. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer. 2009;9:84.
170.
LeeSKolonelLWilkensLWanPHendersonBPikeM. Postmenopausal hormone therapy and breast cancer risk: the multiethnic cohort. Int J Cancer. 2006;118:1285-1291.
171.
LiCIMaloneKEPorterPL. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev. 2008;17: 43-50.
172.
LochnerDMBrubakerKL. Incidence of malignancy in hormone therapy users with indeterminate calcifications on mammogram. Am J Obstet Gynecol. 2006;194:82-85.
173.
LyytinenHKDybaTYlikorkalaOPukkalaEI. A case-control study on hormone therapy as a risk factor for breast cancer in Finland: intrauterine system carries a risk as well. Int J Cancer. 2010;126:483-489.
174.
OpatrnyLDell’AnielloSAssoulineSSuissaS. Hormone replacement therapy use and variations in the risk of breast cancer. BJOG. 2008;115:169-175.
175.
OzmenVOzcinarBKaranlikH. Breast cancer risk factors in Turkish women—a university hospital based nested case control study. World J Surg Oncol. 2009;7:37.
176.
PeschBKoYBrauchH. Factors modifying the association between hormone-replacement therapy and breast cancer risk. Eur J Epidemiol. 2005;20:699-711.
177.
QuickSKShieldsPGNieJ. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17:1082-1087.
178.
RennertGPinchevMRennertHS. Use of bisphosphonates and risk of postmenopausal breast cancer. J Clin Oncol. 2010;28:3577-3581.
179.
SaekiTSanoMKomoikeY. No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan. Int J Clin Oncol. 2008;13:8-11.
180.
SaxenaTLeeEHendersonKD. Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study. Cancer Epidemiol Biomarkers Prev. 2010;19:2366-2378.
181.
SlatteryMLEdwardsSMurtaughMA. Physical activity and breast cancer risk among women in the southwestern United States. Ann Epidemiol. 2007;17:342-353.
182.
SpragueBLTrentham-DietzAEganKMTitus-ErnstoffLHamptonJMNewcombPA. Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol. 2008;168:404-411.
183.
StahlbergCLyngeEAndersenZJ. Breast cancer incidence, case-fatality and breast cancer mortality in Danish women using hormone replacement therapy—a prospective observational study. Int J Epidemiol. 2005;34:931-935.
184.
TrabertBMaloneKEDalingJR. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res. 2007;9:R84.
185.
VickersMRMacLennanAHLawtonB. Main morbidities recorded in the Women’s International Study of long Duration Oestrogen after Menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ. 2007;335:239-244.
186.
ZipprichJBeth TerryMLiaoY. Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York Site of the breast cancer family registry. Cancer Research. 2009;69:2966-2972.
187.
WeaverDLVacekPMSkellyJMGellerBM. Predicting biopsy outcome after mammography: what is the likelihood the patient has invasive or in situ breast cancer?Ann Surg Oncol. 2005;12:660-673.
188.
LaceyJVJrKreimerARBuysSS. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer. 2009;9:84.
189.
VickersMRMartinJMeadeTW. The Women’s International Study of Long-Duration Oestrogen after Menopause (WISDOM): a randomised controlled trial. BMC Women’s Health. 2007;7:2.
190.
WeiderpassEGridleyGPerssonINyrenOEkbomAAdamiHO. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer. 1997;71:360-363.
191.
HjalgrimHFrischMEkbomAKyvikKOMelbyeMGreenA. Cancer and diabetes—a follow-up study of two population-based cohorts of diabetic patients. J Intern Med. 1997;241:471-475.
192.
WideroffLGridleyGMellemkjaerL. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997;89:1360-1365.
193.
SwerdlowAJLaingSPQiaoZ. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer. 2005;92:2070-2075.
194.
O’MaraBAByersTSchoenfeldE. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis. 1985;38:435-441.
195.
FranceschiSLa VecchiaCNegriEParazziniFBoyleP. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer. 1990;26:781-785.
196.
TalaminiRFranceschiSFaveroANegriEParazziniFLa VecchiaC. Selected medical conditions and risk of breast cancer. Br J Cancer. 1997;75:1699-1703.
197.
WeissHABrintonLAPotischmanNA. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol. 1999;28:816-823.
198.
BaronJAWeiderpassENewcombPA. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control. 2001;12:875-880.
199.
de WaardFBaanders-van HalewijnEA. A prospective study in general practice on breast-cancer risk in postmenopausal women. Int J Cancer. 1974;14:153-160.
200.
RagozzinoMMeltonLJ3rdChuCPPalumboPJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis. 1982;35:13-19.
201.
SellersTASprafkaJMGapsturSM. Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer?Epidemiology. 1994;5:102-108.
202.
SteenlandKNowlinSPaluS. Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev. 1995;4:807-811.
203.
GoodmanMTCologneJBMoriwakiHVaethMMabuchiK. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med. 1997;26:144-153.
204.
MinkPJShaharERosamondWDAlbergAJFolsomAR. Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol. 2002;156:349-352.
205.
MichelsKBSolomonCGHuFB. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care. 2003;26:1752-1758.
206.
JeeSHOhrrHSullJWYunJEJiMSametJM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293:194-202.
207.
KhanMMoriMFujinoY. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev. 2006;7:253-259.
208.
LipscombeLLGoodwinPJZinmanBMcLaughlinJRHuxJE. Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat. 2006;98:349-356.
209.
InoueMIwasakiMOtaniTSasazukiSNodaMTsuganeS. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166:1871-1877.
210.
ChodickGHeymannADRosenmannL. Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control. 2010;21:879-887.
211.
SellersTAJensenLEVierkantRA. Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Causes Control. 2007;18:505-515.
212.
JordanSLimLVilainerunD. Breast cancer in the Thai Cohort Study: an exploratory case-control analysis. Breast. 2009;18:299-303.
213.
RollisonDEGiulianoARSellersTA. Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol. 2008;167:447-456.
214.
SandersonMPeltzGPerezA. Diabetes, physical activity and breast cancer among Hispanic women. Cancer Epidemiol. 2010;34:556-561.
215.
WuAHYuMCTsengCCStanczykFZPikeMC. Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis. 2007;28:1561-1566.
216.
YangLJacobsenKH. A systematic review of the association between breastfeeding and breast cancer. J Womens Health (Larchmt). 2008;17:1635-1645.
217.
PressDJPharoahP. Risk factors for breast cancer: a reanalysis of two case-control studies from 1926 and 1931. Epidemiology. 2010;21:566-572.
218.
HuoDAdebamowoCAOgundiranTO. Parity and breastfeeding are protective against breast cancer in Nigerian women. Br J Cancer. 2008;98:992-996.
219.
GajalakshmiVMathewABrennanP. Breastfeeding and breast cancer risk in India: a multicenter case-control study. Int J Cancer. 2009;125:662-665.
220.
AkbariMEAkbariAHomaeeFTabatabaeeMKhayamzadehM. Parity and breast feeding are preventive measures for breast cancer in Iranian women. Eur J Cancer Suppl. 2010;8:212.
221.
AwatefMOlfaGImedH. Breastfeeding reduces breast cancer risk: a case-control study in Tunisia. Cancer Causes Control. 2010;21:393-397.
222.
De SilvaMSenarathUGunatilakeMLokuhettyD. Prolonged breastfeeding reduces risk of breast cancer in Sri Lankan women: a case-control study. Cancer Epidemiol. 2010;34:267-273.
223.
Hajian-TilakiKOKaveh-AhangarT. Reproductive factors associated with breast cancer risk in northern Iran. Med Oncol. 2011;28:441-446.
224.
LordSJBernsteinLJohnsonKA. Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev. 2008;17:1723-1730.
225.
MaHHendersonKDSullivan-HalleyJ. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res. 2010;12:R35.
226.
NemesureBWuSYHambletonIRLeskeMCHennisAJ. Risk factors for breast cancer in a black population—the Barbados National Cancer Study. Int J Cancer. 2009;124:174-179.
227.
OzmenVOzcinarBKaranlikH. Breast cancer risk factors in Turkish women—a university hospital based nested case control study. World J Surg Oncol. 2009;7:37.
228.
PetersonNBHuangYNewcombPA. Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17:3284-3287.
229.
PhippsAIMaloneKEPorterPLDalingJRLiCI. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer. 2008;113:1521-1526.
230.
SchmidtMEChang-ClaudeJSlangerTObiNFlesch-JanysDSteindorfK. Physical activity and postmenopausal breast cancer: effect modification by other breast cancer risk factors. Methods Inf Med. 2009;48:444-450.
231.
StuebeAMWillettWCXueFMichelsKB. Lactation and incidence of premenopausal breast cancer: a longitudinal study. Arch Intern Med. 2009;169:1364-1371.
232.
UlusoyCKepenekciIKoseKAydintugSCamR. Applicability of the gail model for breast cancer risk assessment in turkish female population and evaluation of breastfeeding as a risk factor. Breast Cancer Res Treat. 2010;120:419-424.
233.
XingPLiJJinF. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol. 2010;27:926-931.
234.
TryggvadottirLTuliniusHEyfjordJESigurvinssonT. Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study. Am J Epidemiol. 2001;154:37-42.
235.
GaoYTShuXODaiQ. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer. 2000;87:295-300.
236.
Chang-ClaudeJEbyNKiechleMBastertGBecherH. Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control. 2000;11:687-695.
237.
CooganPFRosenbergLShapiroSHoffmanM. Lactation and breast carcinoma risk in a South African population. Cancer. 1999;86:982-989.
238.
KimYChoiJYLeeKM. Dose-dependent protective effect of breast-feeding against breast cancer among ever-lactated women in Korea. Eur J Cancer Prev. 2007;16:124-129.
239.
KishkNA. Breast cancer in relation to some reproductive factors. J Egypt Public Health Assoc. 1999;74:547-566.
240.
KuruBOzaslanCOzdemirPDincSCamlibelMAlagolH. Risk factors for breast cancer in Turkish women with early pregnancies and long-lasting lactation—a case-control study. Acta Oncol. 2002;41:556-561.
241.
LeeEOAhnSHYouC. Determining the main risk factors and high-risk groups of breast cancer using a predictive model for breast cancer risk assessment in South Korea. Cancer Nurs. 2004;27:400-406.
242.
MagnussonCMPerssonIRBaronJAEkbomABergstromRAdamiHO. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years. Int J Cancer. 1999;80:231-236.
243.
NewcombPAEganKMTitus-ErnstoffL. Lactation in relation to postmenopausal breast cancer. Am J Epidemiol. 1999;150:174-182.
244.
Olaya-ContrerasPPierreBLazcano-PonceEVillamil-RodriguezJPosso-ValenciaHJ. Reproductive risk factors associated with breast cancer in Colombian women [in Spanish]. Rev Saude Publica. 1999;33:237-245.
245.
OranBCelikIErmanM. Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women: a case-control study. Med Oncol. 2004;21:31-40.
246.
Ortiz MendozaCMGalván MartínezEA. Reproductive risk factors of breast cancer in patients attended at a second level urban hospital [in Spanish]. Ginecol Obstet Mex. 2007;75:11-16.
247.
PurwantoHSadjiminTDwiprahastoI. Lactation and the risk of breast cancer. Gan To Kagaku Ryoho. 2000;27(suppl 2):474-481.
248.
ShemaLOreLBen-ShacharMHajMLinnS. The association between breastfeeding and breast cancer occurrence among Israeli Jewish women: a case control study. J Cancer Res Clin Oncol. 2007;133:539-546.
249.
ZhengTHolfordTRMayneST. Lactation and breast cancer risk: a case-control study in Connecticut. Br J Cancer. 2001;84:1472-1476.
250.
ZhengTDuanLLiuY. Lactation reduces breast cancer risk in Shandong Province, China. Am J Epidemiol. 2000;152:1129-1135.
251.
BrignoneGCusimanoRDardanoniG. A case-control study on breast cancer risk factors in a southern European population. Int J Epidemiol. 1987;16:356-361.
252.
BrintonLAHooverRFraumeniJFJr.Reproductive factors in the aetiology of breast cancer. Br J Cancer. 1983;47:757-762.
253.
BrintonLAPotischmanNASwansonCA. Breastfeeding and breast cancer risk. Cancer Causes Control. 1995;6:199-208.
254.
EngerSMRossRKHendersonBBernsteinL. Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer. 1997;76:118-123.
255.
EngerSMRossRKPaganini-HillABernsteinL. Breastfeeding experience and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1998;7:365-369.
256.
FreudenheimJLMarshallJRVenaJE. Lactation history and breast cancer risk. Am J Epidemiol. 1997;146:932-938.
257.
GillilandFDHuntWCBaumgartnerKB. Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women’s Health Study. Am J Epidemiol. 1998;148:683-692.
258.
KatsouyanniKLipworthLTrichopoulouASamoliEStuverSTrichopoulosD. A case-control study of lactation and cancer of the breast. Br J Cancer. 1996;73:814-818.
259.
LaydePMWebsterLABaughmanALWingoPARubinGLOryHW. The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol. 1989;42:963-973.
260.
McCredieMPaulCSkeggDCWilliamsS. Reproductive factors and breast cancer in New Zealand. Int J Cancer. 1998;76:182-188.
261.
MacMahonBPurdeMCramerDHintE. Association of breast cancer risk with age at first and subsequent births: a study in the population of the Estonian Republic. J Natl Cancer Inst. 1982;69:1035-1038.
262.
McTiernanAThomasDB. Evidence for a protective effect of lactation on risk of breast cancer in young women. Results from a case-control study. Am J Epidemiol. 1986;124:353-358.
263.
NegriEBragaCLa VecchiaCLeviFTalaminiRFranceschiS. Lactation and the risk of breast cancer in an Italian population. Int J Cancer. 1996;67:161-164.
264.
NewcombPAStorerBELongneckerMP. Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med. 1994;330:81-87.
265.
RaoDNGaneshBDesaiPB. Role of reproductive factors in breast cancer in a low-risk area: a case-control study. Br J Cancer. 1994;70:129-132.
266.
RomieuIHernandez-AvilaMLazcanoELopezLRomero-JaimeR. Breast cancer and lactation history in Mexican women. Am J Epidemiol. 1996;143:543-552.
267.
Rosero-BixbyLOberleMWLeeNC. Reproductive history and breast cancer in a population of high fertility, Costa Rica, 1984-85. Int J Cancer. 1987;40:747-754.
268.
RossRKYuMC. Breast-feeding and breast cancer. N Engl J Med. 1994;330:1683.
269.
SiskindVSchofieldFRiceDBainC. Breast cancer and breastfeeding: results from an Australian case-control study. Am J Epidemiol. 1989;130:229-236.
270.
ThomasDBNoonanEA. Breast cancer and prolonged lactation. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol. 1993;22:619-626.
271.
WuAHZieglerRGPikeMC. Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer. 1996;73:680-686.
272.
LubinJHBurnsPEBlotWJ. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst. 1982;68:211-217.
273.
GermainD. Estrogen carcinogenesis in breast cancer. Endocrinol Metab Clin North Am. 2011;40:473-484.
274.
YagerJDDavidsonNE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006;354:270-282.
275.
RussoJMoralRBaloghGAMailoDRussoIH. The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005;7:131-142.
276.
BernsteinL. Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia. 2002;7:3-15.
277.
KeyTApplebyPBarnesIReevesG. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94:606-616.
278.
NyholmHDjursingHHagenCAgnerTBennettPSvenstrupB. Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab. 1989;69:946-949.
279.
JemalASiegelRXuJWardE. Cancer statistics, 2010. CA: Cancer J Clin. 2010;60:277-300.
280.
GailMHBrintonLAByarDP. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-1886.
281.
RosnerBColditzGA. Nurses’ health study: log-incidence mathematical model of breast cancer incidence. J Natl Cancer Inst. 1996;88:359-364.
282.
AnothaisintaweeTTeerawattananonYWiratkapunCKasamesupVThakkinstianA. Risk prediction models of breast cancer: a systematic review of model performances. Breast Cancer Res Treat. 2012;133:1-10.
283.
VesseyMPainterR. Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer. 2006;95:385-389.
284.
HunterDJColditzGAHankinsonSE. Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiol Biomarkers Prev. 2010;19:2496-2502.
285.
YangCPWeissNSBandPRGallagherRPWhiteEDalingJR. History of lactation and breast cancer risk. Am J Epidemiol. 1993;138:1050-1056.
286.
LumachiFErmaniMBrandesAA. Breast cancer risk in healthy and symptomatic women: results of a multivariate analysis. A case-control study. Biomed Pharmacother. 2002;56:416-420.
287.
TessaroSBeriaJUTomasiEVictoraCG. Breastfeeding and breast cancer: a case-control study in southern Brazil. Cad Saude Publica. 2003;19:1593-1601.
288.
HejarARChongFBRosnanHZailinaH. Breast cancer and lifestyle risks among Chinese women in the Klang Valley in 2001. Med J Malaysia. 2004;59:226-232.
289.
AkbariARazzaghiZHomaeeFKhayamzadehMMovahediMAkbariME. Parity and breastfeeding are preventive measures against breast cancer in Iranian women. Breast Cancer. 2011;18:51-55.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
